Biodexa Pharmaceuticals (BDRX)
NASDAQ: BDRX
· Real-Time Price · USD
1.16
0.01 (0.87%)
At close: Jun 03, 2025, 3:59 PM
1.16
0.42%
After-hours: Jun 03, 2025, 07:52 PM EDT
0.87% (1D)
| Bid | 1.11 |
| Market Cap | 1.93K |
| Revenue (ttm) | 83K |
| Net Income (ttm) | -6.82M |
| EPS (ttm) | -13.43 |
| PE Ratio (ttm) | -0.09 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.2 |
| Volume | 284,101 |
| Avg. Volume (20D) | 2,611,149 |
| Open | 1.12 |
| Previous Close | 1.15 |
| Day's Range | 1.12 - 1.18 |
| 52-Week Range | 1.01 - 41.50 |
| Beta | 1.16 |
About BDRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BDRX
Website n/a
1 week ago
+6.92%
Biodexa Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
3 weeks ago
-12.77%
BDRX stock has given up its prior gain. Biodexa Pharmaceuticals shares were trading higher after the company received orphan drug designation in Europe for eRapa in treating familial adenomatous polyposis.
